| 000 -LEADER |
|---|
| fixed length control field |
00607nam a22002057a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20130427110937.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
130427b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
UG |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC388 .5 W5 |
| 110 2# - MAIN ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Healthy Organizations. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Cerebrovascular disease : |
| Remainder of title |
prevention, treatment and rehabilitation. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Geneva : |
| Name of publisher, distributor, etc |
WHO, |
| Date of publication, distribution, etc |
1971. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
57 p. |
| 490 1# - SERIES STATEMENT |
|---|
| Series statement |
(WHO technical report series |
| Volume number/sequential designation |
no. 469) |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Report of a WHO meeting. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cerebrovascular disease. |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
World Health Organization. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Verified |
SM |